- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00833924
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Low Profile AAA Endovascular Graft
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Expanded Access
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- Queen Mary Hospital
-
-
-
-
-
Munster, Germany, 48145
- St. Franziskus Hospital
-
-
-
-
-
Moscow, Russian Federation, 111123
- CELT Hospital
-
-
-
-
-
Malmo, Sweden
- Malmö University Hospital
-
-
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco, Div. Vascular Surgery and San Francisco VAMC
-
Stanford, California, United States, 94305
- Stanford University Medical Center
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale New Haven School of Med., Dept. of Vascular Surgery
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida, Vascular Surgery
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Hospital
-
Grand Rapids, Michigan, United States, 49546
- Spectrum Health Butterworth
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Missouri
-
Saint Louis, Missouri, United States, 63141
- Mercy Hospital
-
Saint Louis, Missouri, United States, 63141
- Barnes-Jewish Hospital
-
-
New Jersey
-
Morristown, New Jersey, United States, 07960
- Morristown Memorial Hospital
-
-
New York
-
New York, New York, United States, 10016
- New York University Hospital
-
New York, New York, United States, 10032
- New York Presbyterian Hospital - Cornell
-
Rochester, New York, United States, 14642
- University of Rochester, Strong Memorial Hospital
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27955
- University of North Carolina
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
Columbus, Ohio, United States, 43214
- Ohio Health Research Institute
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15212
- Allegheny General Hospital
-
-
Virginia
-
Falls Church, Virginia, United States, 22042
- Fairfax INOVA Hospital
-
-
Washington
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53215
- St. Luke's Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Abdominal aortic, aortoiliac, and iliac aneurysms of appropriate size
- Vessels suitable for endovascular access and aneurysm repair
Exclusion Criteria:
- Less than 18 years of age
- Inability or refusal to give informed consent
- Disease considerations that would compromise patient safety or study outcomes
- Unsuitable arterial anatomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: 1
Treatment with Endovascular Graft
|
The Zenith(R) Low Profile AAA Endovascular Graft and ancillary components are indicated for the endovascular treatment of patients with abdominal aortic, aorto-iliac, or iliac aneurysms having morphology suitable for endovascular repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients With Major Adverse Events (MAE)
Time Frame: 30-day
|
MAE is defined as any occurrence of all-cause death, Q-wave myocardial infarction (MI), renal failure requiring dialysis, paralysis, stroke, bowel ischemia, or re-intubation.
|
30-day
|
Patients With Device Failures
Time Frame: 12-month
|
Device success at 12-month is defined as: Technical Success (successful access of the aneurysm site, deployment of the graft in the intended location, and patency of the graft at the time of deployment completion intra-operatively), and freedom from the following at 12 months: Type I or type III endoleaks requiring re-intervention, Aneurysm rupture or conversion to open surgical repair, and Aneurysm enlargement greater than 0.5 cm. |
12-month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-013
- 370016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysms
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac AneurysmsUnited States, Canada
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Group IncorporatedNo longer availableAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
Cook Group IncorporatedApproved for marketingAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Rijnstate HospitalW.L.Gore & AssociatesActive, not recruitingAneurysm | Abdominal Aortic Aneurysms | Common Iliac AneurysmsItaly, New Zealand, Netherlands, Spain
-
Endospan Ltd.CompletedAortoiliac Aneurysms | Infrarenal Abdominal Aortic AneurysmsItaly, Serbia, Netherlands, Switzerland
-
Gustavo OderichCook Group IncorporatedRecruitingJuxtarenal Aortic Aneurysms | Suprarenal Aortic Aneurysms | Type IV Thoracoabdominal Aortic AneurysmsUnited States
-
University of WashingtonRecruiting
-
Medtronic CardiovascularCompletedAbdominal Aortic AneurysmsUnited States
-
Medtronic CardiovascularNo longer availableAbdominal Aortic AneurysmsUnited States
Clinical Trials on Zenith(R) Low Profile AAA Endovascular Graft
-
Cook Group IncorporatedNo longer availableAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Iliac AneurysmsUnited States
-
Cook Group IncorporatedTerminatedAbdominal Aortic Aneurysm | Aorto-iliac AneurysmNetherlands, United Kingdom, Germany, Norway, Austria, Ireland, Italy
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac AneurysmsUnited States, Canada
-
Cook Group IncorporatedCompletedAbdominal Aortic Aneurysms | Aorto-iliac Aneurysms | Juxtarenal AneurysmsUnited States
-
Cook Group IncorporatedApproved for marketingAortic Aneurysm | Vascular Disease | Penetrating UlcerUnited States
-
Cook Research IncorporatedCompletedThoracic Injuries | Thoracic Aorta | Blunt InjuriesUnited States
-
Cook Research IncorporatedCompletedAortic Aneurysm | Vascular Disease | Penetrating UlcerUnited States, Japan, Germany, Italy, Sweden, United Kingdom
-
University of California, San FranciscoRecruitingAbdominal Aortic AneurysmUnited States
-
Cook Group IncorporatedTerminatedAorto-iliac Aneurysms | Iliac AneurysmsHong Kong, United Kingdom, Germany
-
Cook Research IncorporatedCompletedAbdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal AneurysmUnited States